← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Caleres had no revenue row in the FY2025 bundle, swung to a $6.7M net loss, and produced lower FCF despite positive cash from ops.
The read at a glance✓ Audited against SEC data
- Business mix — Footwear retail and brandsNote
- Revenue — No revenue rowNote
- Net income — Loss $6.7M vs profitWatch
- FCF — $39.4M, -28.8%Watch
- Buybacks — $5.0M, -92.2%Note
- Insiders — 0 purchases / 0 salesNote
- Accounting — Forensic screen unavailableNote
Business
Caleres is a footwear company with Famous Footwear retail stores and a Brand Portfolio that includes owned and licensed footwear brands.
Where the revenue comes from
Fiscal 2025, as CALERES INC reports it. History and quarterly detail are in the app.
- Famous Footwear$1.5B
- Brand Portfolio$1.3B
Leadership changes
From CALERES INC's own filings, the day they're filed.
- Daniel L. Karpel · Chief Financial Officer · appointmenteff. 2026-05-20
- Daniel L. Karpel · Chief Accounting Officer · appointmenteff. 2026-01-21
- P. Calandra · Chief Financial Officer · departureeff. 2026-01-15
Latest filings
- 10-Q · Quarterly report2026-06-09
- 8-K · Company announcement2026-06-04
- 8-K · Company announcement2026-05-28
- 8-K · Company announcement2026-05-20
- DEF 14A · Annual proxy (pay & governance)2026-04-16
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CALERES INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.